{"nct_id":"NCT00362466","title":"A Study of Dasatinib vs. High-Dose Imatinib (600 mg) in Patients With Chronic Phase Chronic Myeloid Leukemia (CML) Who Failed to Achieve Complete Cytogenetic Response After 3-18 Months of Imatinib Therapy","status":"TERMINATED","status_verified_date":"2009-11","start_date":"2007-04","start_date_type":null,"primary_completion_date":"2008-06","primary_completion_date_type":"ACTUAL","completion_date":"2008-06","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["BMY"]}